Rilpivirine hydrochloride

Commodity a leaf — nothing below it, 8 links to KBLI

Level: Commodity
Parent: 51343700
Below: 0
Links · KBLI: 8

Definition

UNSPSC 51343705

This classification denotes a reverse transcriptase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 212WAX8KDD. European Medicines Agency schedules Rilpivirine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB31460. Rilpivirine hydrochloride generally arises in the molecular formula C22H18N6.CLH. The term 'rilpivirine hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule rilpivirine hydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, RILPIVIRINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CC1CC(CC(C1NC2CCNC(N2)NC3CCC(CC3)C#N)C)/C=C/C#N.CL.

Same parent

Under 51343700 · 5

51343701 Tanomastat Commodity 51343702 Moroxydine Commodity 51343703 Rilpivirine Commodity 51343704 Etravirine Commodity 51343705 Rilpivirine hydrochloride You are here

Activities that produce or sell this

KBLI · 8

Inherited from family 51340000.

21012 Industri Produk Farmasi untuk Manusia Sub-class 21013 Industri Produk Farmasi untuk Hewan Sub-class 46441 Perdagangan Besar Sediaan Farmasi untuk Manusia Sub-class 46442 Perdagangan Besar Sediaan Farmasi untuk Hewan Sub-class 46902 Perdagangan Besar Berbagai Macam Barang Selain di Grosir/Perkulakan Swalayan Sub-class 47721 Perdagangan Eceran Sediaan Farmasi untuk Manusia di Apotek Sub-class 47722 Perdagangan Eceran Sediaan Farmasi untuk Manusia Selain di Apotek Sub-class 47726 Perdagangan Eceran Obat Farmasi untuk Hewan Sub-class

Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.